Institutional investors hold a majority ownership of EXAS through the 96.84% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended June 2014, these large investors purchased a net $16.5 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CAPITAL RESEARCH & MANAGEMENT CO... Bought 3.4 Million shares of Exact Sciences Corp
PRIMECAP MANAGEMENT CO. Bought 2.5 Million shares of Exact Sciences Corp
WILLIAM BLAIR & CO. LLC (INVESTM... Bought 2.2 Million shares of Exact Sciences Corp